When is it appropriate to use code 38242 (REVISED IN 2013), Allogenic lymphocyte infusions versus code 38243 , HPC [hematopoietic progenator cell] boost? ...
Subscribe or sign in to view the full article.
Article Overview
This article is a short coding reference for transplant-related cellular therapy services. It is aimed at coders, billers, and clinical documentation staff who need to distinguish between two allogeneic post-transplant procedures and understand the general settings in which they are addressed. The discussion stays at a high level, focusing on the overall purpose of each service, the transplant context, and how the article frames the distinction between the two code categories.
Why This Topic Matters
Accurate selection of transplant-related procedure codes depends on understanding which broad type of cellular product was provided and the overall post-transplant indication being addressed. This article helps readers orient themselves to that distinction without replacing the full coding guidance.
What You Will Learn
- The general difference between two transplant-related cellular therapy procedures
- How the article frames post-transplant clinical contexts for these services
- What broad documentation themes are relevant when reviewing these procedure categories
- How the article relates cellular product type to the corresponding service category
Who Should Read This
- Medical coders
- Billing staff
- HIM professionals
- Transplant documentation specialists
- Clinical coding auditors
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com